<p>Differences in CSF lymphocyte populations and clinical parameters between MS patients with (SPMS and PPMS) and without disease progression (CIS, RRMS).</p
<p>(A) CD19<sup>+</sup> B cell subtype proportion and (B) CD4<sup>+</sup> T cell subtype proportion ...
Objective: To establish cytometry profiles associated with disease stages and immunotherapy in MS. M...
Objective: Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by autoim...
<p>Comparison of CSF and blood parameters between patients with MS and other inflammatory CNS disord...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
OBJECTIVE: To identify an MS-specific immune cell population by deep immune phenotyping and relate i...
OBJECTIVE To identify an MS-specific immune cell population by deep immune phenotyping and relate...
OBJECTIVE To identify an MS-specific immune cell population by deep immune phenotyping and relate...
OBJECTIVE To identify an MS-specific immune cell population by deep immune phenotyping and relate...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
<p>Analysis of CSF and PBMC from 17 treatment-naïve MS patients. Isolated lymphocytes were stained w...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-t003" ...
<p>Table 6 shows the results of linear regression analyses on parameters identified in the previous ...
<p>Data are expressed as median and range (in brackets). There were no statistically significant dif...
<p>(A) CD19<sup>+</sup> B cell subtype proportion and (B) CD4<sup>+</sup> T cell subtype proportion ...
Objective: To establish cytometry profiles associated with disease stages and immunotherapy in MS. M...
Objective: Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by autoim...
<p>Comparison of CSF and blood parameters between patients with MS and other inflammatory CNS disord...
<p>Abbreviations: NCAND, Non-CNS-autoimmune neurological disorders; CAND, CNS-autoimmune neurologica...
OBJECTIVE: To identify an MS-specific immune cell population by deep immune phenotyping and relate i...
OBJECTIVE To identify an MS-specific immune cell population by deep immune phenotyping and relate...
OBJECTIVE To identify an MS-specific immune cell population by deep immune phenotyping and relate...
OBJECTIVE To identify an MS-specific immune cell population by deep immune phenotyping and relate...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
<p>Analysis of CSF and PBMC from 17 treatment-naïve MS patients. Isolated lymphocytes were stained w...
<p>p<0.01 is considered statistically significant. Comparisons are pairwise. Bars show mean values, ...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-t003" ...
<p>Table 6 shows the results of linear regression analyses on parameters identified in the previous ...
<p>Data are expressed as median and range (in brackets). There were no statistically significant dif...
<p>(A) CD19<sup>+</sup> B cell subtype proportion and (B) CD4<sup>+</sup> T cell subtype proportion ...
Objective: To establish cytometry profiles associated with disease stages and immunotherapy in MS. M...
Objective: Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by autoim...